About RevOpsis
RevOpsis is a private company based in Tampa, Florida, incorporated in 2025 in Delaware. It has reported $1 raised in one offering on Form D since July 2025. Its chief executive is Ramanath Bhandari.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | Jul 15, 2025 | $1target not set | 66 | $0 | Equity, Options, Securities on exerciseRule 506(c) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on RevOpsis's Form D filed Jul 15, 2025.

Ram Palanki
Chief Strategic Advisor and director
Ram Palanki appears on 6 Form D filings at 3 companies:
- RevOpsis Therapeutics, executive officer and director: Jun 27, 2022
- RevOpsis, chief strategic advisor and director: Jul 29, 2022 · Aug 24, 2022 · Aug 10, 2023 · Nov 7, 2024
- RevOpsis, chief strategic advisor and director: Jul 15, 2025

Jeff Olson
Co-founder & Board of Directors
Jeff Olson appears on 4 Form D filings at 3 companies:
- RevOpsis Therapeutics, director: Jun 27, 2022
- RevOpsis, director: Jul 29, 2022 · Aug 24, 2022
- RevOpsis, co-founder & board of directors: Jul 15, 2025

Ramanath Bhandari
Co-founder, CEO, & Board Chairman
Ramanath Bhandari appears on 6 Form D filings at 3 companies:
- RevOpsis Therapeutics, interim CEO and director: Jun 27, 2022
- RevOpsis, co-founder, CEO, & board chairman: Jul 29, 2022 · Aug 24, 2022 · Aug 10, 2023 · Nov 7, 2024
- RevOpsis, co-founder, CEO, & board chairman: Jul 15, 2025
